A total of 577 patients were randomly assigned (1:1:1) to receive once-weekly dulaglutide (1.5 mg), once-weekly dulaglutide (0.75 mg), or daily insulin glargine as basal therapy, all in combination with insulin lispro, for 52 weeks
Treatment typically begins at a lower starting dose, which is gradually adjusted under medical supervision to reduce side effects and support safe progress
Take the first step toward better health and join the growing community of Wisconsinites who've discovered this powerful, natural approach to vitality
doi:10.1371/journal.pmed.1004039
Electrolytes become especially important if nausea or reduced food intake leads to mineral loss
G., Brooks, L., Bewick, G